These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 30665954)

  • 1. Type 1 Diabetes in STAT Protein Family Mutations: Regulating the Th17/Treg Equilibrium and Beyond.
    Fabbri M; Frixou M; Degano M; Fousteri G
    Diabetes; 2019 Feb; 68(2):258-265. PubMed ID: 30665954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human T
    Zhang Y; Siegel AM; Sun G; Dimaggio T; Freeman AF; Milner JD
    J Allergy Clin Immunol; 2019 Mar; 143(3):1108-1118.e4. PubMed ID: 30030006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Signal transducer and activator of transcription gain-of-function primary immunodeficiency/immunodysregulation disorders.
    Consonni F; Dotta L; Todaro F; Vairo D; Badolato R
    Curr Opin Pediatr; 2017 Dec; 29(6):711-717. PubMed ID: 28914637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. STAT1 and STAT3 mutations: important lessons for clinical immunologists.
    Olbrich P; Freeman AF
    Expert Rev Clin Immunol; 2018 Dec; 14(12):1029-1041. PubMed ID: 30280610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ruxolitinib reverses dysregulated T helper cell responses and controls autoimmunity caused by a novel signal transducer and activator of transcription 1 (STAT1) gain-of-function mutation.
    Weinacht KG; Charbonnier LM; Alroqi F; Plant A; Qiao Q; Wu H; Ma C; Torgerson TR; Rosenzweig SD; Fleisher TA; Notarangelo LD; Hanson IC; Forbes LR; Chatila TA
    J Allergy Clin Immunol; 2017 May; 139(5):1629-1640.e2. PubMed ID: 28139313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Relevance of Gain- and Loss-of-Function Germline Mutations in STAT1: A Systematic Review.
    Zhang W; Chen X; Gao G; Xing S; Zhou L; Tang X; Zhao X; An Y
    Front Immunol; 2021; 12():654406. PubMed ID: 33777053
    [No Abstract]   [Full Text] [Related]  

  • 7. Human CD39
    Magid-Bernstein JR; Rohowsky-Kochan CM
    J Interferon Cytokine Res; 2017 Apr; 37(4):153-164. PubMed ID: 28387597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human gain-of-function STAT1 mutation disturbs IL-17 immunity in mice.
    Tamaura M; Satoh-Takayama N; Tsumura M; Sasaki T; Goda S; Kageyama T; Hayakawa S; Kimura S; Asano T; Nakayama M; Koseki H; Ohara O; Okada S; Ohno H; Kobayashi M
    Int Immunol; 2020 Apr; 32(4):259-272. PubMed ID: 31867619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Common variable immunodeficiency, impaired neurological development and reduced numbers of T regulatory cells in a 10-year-old boy with a STAT1 gain-of-function mutation.
    Kobbe R; Kolster M; Fuchs S; Schulze-Sturm U; Jenderny J; Kochhan L; Staab J; Tolosa E; Grimbacher B; Meyer T
    Gene; 2016 Jul; 586(2):234-8. PubMed ID: 27063510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activating mutations of STAT3: Impact on human growth.
    Gutiérrez M
    Mol Cell Endocrinol; 2020 Dec; 518():110979. PubMed ID: 32818584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of STAT-3 in rheumatoid synovial T cells suppresses Th17 differentiation and increases the proportion of Treg cells.
    Ju JH; Heo YJ; Cho ML; Jhun JY; Park JS; Lee SY; Oh HJ; Moon SJ; Kwok SK; Park KS; Park SH; Kim HY
    Arthritis Rheum; 2012 Nov; 64(11):3543-52. PubMed ID: 22736176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotypes of STAT3 gain-of-function variant related to disruptive regulation of CXCL8/STAT3, KIT/STAT3, and IL-2/CD25/Treg axes.
    Marega LF; Sabino JS; Pedroni MV; Teocchi M; Lanaro C; de Albuquerque DM; Dos Santos IP; Costa FF; Dos Santos Vilela MM
    Immunol Res; 2021 Oct; 69(5):445-456. PubMed ID: 34390446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Th17 cells in type 1 diabetes.
    Shao S; He F; Yang Y; Yuan G; Zhang M; Yu X
    Cell Immunol; 2012 Nov; 280(1):16-21. PubMed ID: 23246831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-6-gp130-STAT3 in T cells directs the development of IL-17+ Th with a minimum effect on that of Treg in the steady state.
    Nishihara M; Ogura H; Ueda N; Tsuruoka M; Kitabayashi C; Tsuji F; Aono H; Ishihara K; Huseby E; Betz UA; Murakami M; Hirano T
    Int Immunol; 2007 Jun; 19(6):695-702. PubMed ID: 17493959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A human mutation in STAT3 promotes type 1 diabetes through a defect in CD8+ T cell tolerance.
    Warshauer JT; Belk JA; Chan AY; Wang J; Gupta AR; Shi Q; Skartsis N; Peng Y; Phipps JD; Acenas D; Smith JA; Tamaki SJ; Tang Q; Gardner JM; Satpathy AT; Anderson MS
    J Exp Med; 2021 Aug; 218(8):. PubMed ID: 34115115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alanine-scanning mutagenesis of human signal transducer and activator of transcription 1 to estimate loss- or gain-of-function variants.
    Kagawa R; Fujiki R; Tsumura M; Sakata S; Nishimura S; Itan Y; Kong XF; Kato Z; Ohnishi H; Hirata O; Saito S; Ikeda M; El Baghdadi J; Bousfiha A; Fujiwara K; Oleastro M; Yancoski J; Perez L; Danielian S; Ailal F; Takada H; Hara T; Puel A; Boisson-Dupuis S; Bustamante J; Casanova JL; Ohara O; Okada S; Kobayashi M
    J Allergy Clin Immunol; 2017 Jul; 140(1):232-241. PubMed ID: 28011069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. STAT mutations as program switchers: turning primary immunodeficiencies into autoimmune diseases.
    Lorenzini T; Dotta L; Giacomelli M; Vairo D; Badolato R
    J Leukoc Biol; 2017 Jan; 101(1):29-38. PubMed ID: 27803128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53 controls autoimmune arthritis via STAT-mediated regulation of the Th17 cell/Treg cell balance in mice.
    Park JS; Lim MA; Cho ML; Ryu JG; Moon YM; Jhun JY; Byun JK; Kim EK; Hwang SY; Ju JH; Kwok SK; Kim HY
    Arthritis Rheum; 2013 Apr; 65(4):949-59. PubMed ID: 23280308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunological balance between Treg and Th17 lymphocytes as a key element of type 1 diabetes progression in children.
    Starosz A; Jamiołkowska-Sztabkowska M; Głowińska-Olszewska B; Moniuszko M; Bossowski A; Grubczak K
    Front Immunol; 2022; 13():958430. PubMed ID: 36091019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of STAT3 and STAT5 activity rectifies the imbalance of Th17 and Treg cells in patients with acute coronary syndrome.
    Zheng Y; Wang Z; Deng L; Zhang G; Yuan X; Huang L; Xu W; Shen L
    Clin Immunol; 2015 Mar; 157(1):65-77. PubMed ID: 25572535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.